There May Be Reason For Hope In EXEM's (KOSDAQ:205100) Disappointing Earnings

Soft earnings didn't appear to concern EXEM Co., Ltd.'s (KOSDAQ:205100) shareholders over the last week. We did some digging, and we believe the earnings are stronger than they seem.

earnings-and-revenue-history
KOSDAQ:A205100 Earnings and Revenue History April 1st 2025
Advertisement

Zooming In On EXEM's Earnings

One key financial ratio used to measure how well a company converts its profit to free cash flow (FCF) is the accrual ratio. The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.

EXEM has an accrual ratio of -0.13 for the year to December 2024. That indicates that its free cash flow was a fair bit more than its statutory profit. In fact, it had free cash flow of ₩18b in the last year, which was a lot more than its statutory profit of ₩9.06b. EXEM's free cash flow improved over the last year, which is generally good to see.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On EXEM's Profit Performance

As we discussed above, EXEM has perfectly satisfactory free cash flow relative to profit. Because of this, we think EXEM's earnings potential is at least as good as it seems, and maybe even better! Unfortunately, though, its earnings per share actually fell back over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. At Simply Wall St, we found 1 warning sign for EXEM and we think they deserve your attention.

This note has only looked at a single factor that sheds light on the nature of EXEM's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

Valuation is complex, but we're here to simplify it.

Discover if EXEM might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About KOSDAQ:A205100

EXEM

Operates as an IT performance management and big data platform company Korea and internationally.

Flawless balance sheet with acceptable track record.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7061.6% undervalued
6 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17036.6% undervalued
25 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38026.3% undervalued
16 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7448.8% undervalued
41 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

IM
MAHA A logo
Imthetxarbi on Maha Capital ·

Is It worth SEK 16? Arbitrage opportunity?

Fair Value:SEK 0.681.1k% overvalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AR
MRT logo
ariz_scribe on Marti Technologies ·

$MRT at Roth - Pick of the Panel

Fair Value:US$1.968.7% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CJ
WISE logo
cjimi on Wise Group ·

Wise: A Quality Cross-Border Payments Compounder, But Not A Bargain

Fair Value:UK£12.0232.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8589.7% undervalued
124 users have followed this narrative
2 users have commented on this narrative
35 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9722.1% undervalued
56 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1930.3% undervalued
46 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative